Knowledge Base

[ Discussions | TOC | Search | Post | Reply ]


EDHDofFRdrhbnZax

Category: Tools
From: NY
Date: 1/21/2015
Time: 5:45:48 PM
Remote Name: 94.23.1.20

Comments

Some First Class stamps <a href=" http://www.alternative-regionalisms.org/?p=lincocin ">lincomycin antibiotic</a> Teva Pharmaceuticals, the maker of Plan B, declined to comment on any discussions it may be having with the FDA, and spokeswoman Denise Bradley wrote in an e-mail: “The data submitted in Europe to support the label change on Norlevo is HRA Pharma’s proprietary information, and as such, we have not had the opportunity to review it and cannot provide comment on that data at this time.”


Last changed: 01/21/15